Results
GSK India Q1 PAT Rises 24% to INR 253 Crores
GSK India reported Q1 FY27 revenue of INR 924 crores, up 15% YoY, with PAT growing 24% to INR 253 crores.
Strong growth was driven by the General Medicines portfolio, Vaccines business, and the new On
